Psychemedics

Psychemedics FCF/Debt

The Free Cash Flow to Debt Ratio of Psychemedics (PMDI) as of Oct 30, 2026 is 1,541.97 %. In the previous year, Free Cash Flow to Debt Ratio was 38.73 % — a change of 3,881.20% (higher).

FCF/Debt

1,541.97 %

YoY

3,881.20%

Last updated:

Free Cash Flow to Debt Ratio of Psychemedics is 2022 1,541.97 % . Free Cash Flow to Debt Ratio of Psychemedics was 2021 38.73 % . It decreases by 3,881.20% higher compared to the previous year.

The Psychemedics FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2015
48.05 USD
Jan 1, 2016
214.79 USD
Jan 1, 2017
235.21 USD
Jan 1, 2018
413.50 USD
Jan 1, 2019
100.00 USD
Jan 1, 2020
-147.33 USD
Jan 1, 2021
38.73 USD
Jan 1, 2022
1,541.97 USD
The Psychemedics FCF/Debt history
YEARFCF/DebtYoY
1,541.97 %+3,881.20%
38.73 %-126.29%
-147.33 %-247.33%
100.00 %-75.82%
413.50 %+75.80%
235.21 %+9.50%
214.79 %+347.04%
48.05 %-196.87%
-49.60 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Psychemedics Stock analysis

What does Psychemedics do? Psychemedics Corp provides drug testing services analyzing hair samples for drug presence, offering historical usage patterns and approximate drug intake levels. The company charges customers a per-unit fee for each tested sample, including training for sample collection and storage of positive results. Their primary service targets clients needing drug testing solutions, particularly in sectors requiring regular monitoring of substance use. The firm's technology focuses on hair analysis to deliver detailed insights into drug consumption over time. Psychemedics Corp's revenue model is based on per-unit testing fees, with services including sample collection training and storage of positive samples. Customers pay for each sample tested, leveraging the company's hair analysis technology to monitor drug use patterns. The business operates within the drug testing services segment, serving clients who require reliable and historical data on substance abuse. The company's drug testing services are designed for customers seeking detailed historical data on drug use, with results indicating both the amount ingested and usage patterns over time. Psychemedics Corp generates income through fixed fees per sample tested, covering the full service including sample collection training and positive sample storage. Their focus remains on delivering accurate, long-term drug usage insights through hair analysis. Psychemedics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Psychemedics stock

Free Cash Flow to Debt Ratio of Psychemedics is 1,541.97 % in 2022.

Free Cash Flow to Debt Ratio of Psychemedics changed from 38.73 % to 1,541.97 %, representing a 3,881.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Psychemedics since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Psychemedics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Psychemedics

All Key Metrics — Psychemedics